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Electrocardiography
On admission and every 3 h after admission during the first 24 h, standard 12-lead ECGs were recorded at a paper speed of 25 mm/s and an amplification of 10 mm/mV. ECGs were enlarged 4-fold, photocopied (Minolta Di351, Tokyo, Japan), and the QRS duration in each of the 12-leads was manually measured, enabling up to 4 ms to be measured. As a rule, the shortest QRS duration in a lead without ST deviation was adopted because it was difficult to determine QRS duration strictly in a lead with ST elevation or depression. Measurements of 3 continuous beats by an independent observer unaware of all clinical and angiographic data were averaged for each ECG.
Cardiac Enzyme Concentrations
Blood samples were taken on admission and every 3 h during the first 24 h to determine peak CK concentration as a marker of infarct size.
Outcomes
Follow-up examinations were conducted at the hospital for at least 6 months. Patients who were unable or unwilling to return to the hospital were contacted by telephone. Mortality from all causes was the primary endpoint.
Statistical Analysis
Categorical variables were expressed as percentages and were compared by the chi-square test. Continuous variables were reported as means ± SD and were compared by Student's t-test or one-factor analysis of variance (ANOVA). Survival from the time of presentation was estimated by the Kaplan-Meier method and compared among groups with the log-rank test. Probability values <0.05 were considered to indicate statistical significance.
Results
Baseline Characteristics and Clinical Presentation
There were no differences in sex, coronary risk factors, or time from symptom onset to admission among the 3 groups. Patients in group W were younger than those in group B and of similar age to those in group N. Patients in group W had higher prevalences of previous myocardial infarction, dyspnea as a symptom on admission, and Killip class >1 than did those in group N ( Table 1) .
Angiographic Evaluation
In group W the percentages of patients with 3-vessel disease, severe 3-vessel disease, good collateral flow and who did not have the left anterior descending coronary artery as a culprit artery were higher than in the other 2 groups. There were no differences in the initial or final TIMI flow grades among the 3 groups (Table 2) .
ECG Findings
In the standard 12-lead ECG on admission, the average maximum ST-segment elevation was lower and the rate of maximum ST-segment elevation <0.2 mV were higher in group W than in group N ( Table 1 ). Normalization to <100 ms in QRS duration was more frequently observed within 24 h after successful reperfusion in group W (48 of 61 patients, 79%) than in group B (22 of 50 patients, 44%) (Fig 1) .
Treatment
Coronary thrombolysis, percutaneous coronary intervention, or both were performed in similar proportions of patients in the 3 groups. The rates of intraaortic balloon pumping (IABP) and persistent hypotension requiring continuous catecholamine infusion were higher in groups W and B than in group N. The percentage of patients who underwent coronary artery bypass graft surgery (CABG) during hospitalization was higher in group W than in group N or B (Table 3) .
Infarct Size and Outcome
Although the peak CK concentration did not differ between groups W and B, the proportion of patients with a peak concentration >7,000 IU/L in group W was similar to that in group N, but significantly lower than that in group B (Table 3) .
Six-month follow-up data were available for 458 of 465 patients (99%). All-cause mortality at 6 months in group W was similar to that in group N, but lower than that in group B (4%, 3% vs 25%) (Fig 2) . A similar trend was observed for death from cardiac causes at 6 months (3%, 1% vs 25%). The causes of death are shown in Table 4 . In group W, patients with normalization to <100 ms in QRS duration within 24 h of successful reperfusion were likely to have lower 6-months mortality than those with persistent intermediate QRS prolongation (2% vs 13%, p=0.06), although there were no significant differences in baseline characteristics between the 2 subgroups (data not shown).
Discussion
There have been a few reports of the clinical significance of intermediate QRS prolongation in the acute phase of STEMI, but they did not fully evaluated the angiographic findings and the time course of QRS duration. 14, 15 Our study showed that the clinical and angiographic characteristics of patients with intermediate QRS prolongation in the absence of BBB on the presenting ECG differed from those of patients with normal conduction or BBB. In patients with STEMI intermediate QRS prolongation in the absence of BBB was considered mainly a dynamic phenomenon likely to be improved by successful reperfusion.
In our study, the prevalence of complete right BBB was 9.2% (43 of 465), slightly higher than in the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO-I) trial 16, 17 and the National Registry of Myocardial Infarction 2. 7 The prevalence of intermediate QRS prolongation in the absence of BBB on the presenting ECG (group W) was 15% (71 of 465).
The optimal lead for measurement of QRS duration has not been categorically determined and because ST-segment deviation often precludes the manual measurement of QRS duration, we manually measured the shortest QRS duration in a lead without ST-segment deviation. We assigned patients who had a QRS duration ≥100 ms without BBB on the presenting ECG to group W, because the upper limit of normal QRS duration is generally considered <100 ms, and this criterion has been also used in previous study. 15 Several mechanisms for intermediate QRS prolongation have been proposed. Experimental studies have reported that QRS prolongation is associated with Purkinje-ventricular conduction delay caused by myocardial ischemia. [18] [19] [20] [21] [22] [23] In patients with coronary artery disease, exercise-induced QRS prolongation without BBB is directly related to the number of diseased vessels or segmental contraction abnormalities. 24, 25 Other studies have reported that QRS duration is prolonged by occlusion of the proximal and middle segments of major arteries during percutaneous coronary intervention. 26 In the present study 79% of patients in Group W had a normal QRS duration (<100 ms) within 24 h (mostly within 3 h) of successful reperfusion. Moreover, resolution of intermediate QRS prolongation within 24 h of successful reperfusion tended to be associated with lower 6-month mortality than did persistent intermediate QRS prolongation. These findings suggest that the QRS prolongation in group W on presenting ECGs might have been caused primarily by extensive ischemia and a poor metabolic state, rather than by myocardial fibrosis and increased myocardial mass, which are associated with persistent QRS prolongation. 27 The lower 6-month mortality in group W than in group B, despite the higher rate of more severe coronary artery disease in the former, may be attributed to slow progression of myocardial injury, as indicated by higher rates of good collateral flow and preinfarction angina and more aggressive reperfusion therapy, including IABP and subsequent CABG. Another plausible explanation for the lower mortality in group W is the lower prevalence of large infarcts (as indicated by peak CK >7,000 IU/L), albeit the peak CK concentration did not significantly differ between groups W and B. Indeed, the low mortality in group W, comparable with that in group N, was unexpected because the peak CK concentration and the prevalence of both previous MI and Killip >1 was higher in group W than in group N. The similar rates of large infarcts as indicated by a peak CK >7,000 IU/L and a higher rate of revascularization, especially CABG, to decrease extensive ischemia might have contributed to the relatively favorable clinical outcome.
Clinical Implications
Emergency angiography may be less frequently performed in patients with STEMI presenting with intermediate QRS duration because of a relatively mild deviation of ST-segment elevation and a higher percentage of dyspnea as a symptom on admission than those with normal conduction. Because such patients are likely to have severe coronary artery disease, reperfusion therapy based on their coronary angiographic findings may be warranted. Therefore, the QRS duration, as well as the degree of ST elevation, is important in patients with STEMI.
Study Limitations
The major limitations of our study were the retrospective analysis, single-center focus and a relatively small sample size. Because an invasive treatment strategy was adopted as a rule, we cannot conclude that reperfusion therapy was more effective than conservative therapy in group W. However, the relatively low 6-month mortality despite severe clinical and angiographic evidence suggests that the patients in group W could benefit from reperfusion therapy.
Previous studies have reported that patients with new and persistent BBB have poor outcomes, 4,5 but because we often lacked consistent information as to whether BBB was new or old on the presenting ECG, all patients with BBB were included in the analysis, irrespective of time of onset.
Conclusion
Although patients with intermediate QRS prolongation in the absence of BBB have more severe coronary disease, 6-month mortality was similar to those with normal conduction but lower than those with BBB on the presenting ECG. Furthermore, resolution of intermediate QRS prolongation within 24 h of successful reperfusion tended to be associated with lower 6-month mortality. These results suggest that intermediate QRS prolongation in the absence of BBB in patients with STEMI is a dynamic phenomenon that is likely to be improved by successful reperfusion. 
